Health & Fitness

FDA Panel Endorses Moderna Booster For High Risk, Adults Over 65

The independent panel unanimously recommended the booster dose Thursday, which could affect 70 million recipients of the Moderna vaccine.

On Thursday, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
On Thursday, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. (AP Photo/David Zalubowski, File)

WASHINGTON, DC — An independent panel of advisers for the U.S. Food and Drug Administration voted unanimously on Thursday to recommend a booster dose of the Moderna COVID-19 vaccine for specific groups of vaccinated Americans.

The endorsement includes a booster dose for adults over 65 and those who are considered high risk due to underlying conditions or workplace exposure, The Washington Post reported. The recommendation mirrors those made by the panel for the Pfizer-BioNTech booster, which received emergency use authorization last month.

Nearly 70 million Americans have been fully vaccinated with the Moderna vaccine, the Post reported. FDA officials are expected to make a decision on the Moderna booster within days.

Find out what's happening in Across Americafor free with the latest updates from Patch.

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.